ArticleTheranostics2021

Downregulation of death receptor 4 is tightly associated with positive response of EGFR mutant lung cancer to EGFR-targeted therapy and improved prognosis.

Shuo Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.